You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

mCNV

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Quantitative Metamorphopsia- Measurements in Patients With mCNV

Completed
  • Metamorphopsia
  • App
  • Binningen, Baselland, Switzerland
    Vista Klinik
Dec 8, 2021

Learn More About How Drug Aflibercept Works in Canadian Reduced

Active, not recruiting
  • Myopic Choroidal Neovascularization
  • Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
  • Multiple Locations, Canada
    Many Locations
Jul 25, 2022

Use of Aflibercept Injections Into Eye for Treatment of Eye

Recruiting
  • Retinal Disease
  • Aflibercept (BAY86-5321, Eylea)
  • Multiple Locations, Mexico
    Many locations
Aug 22, 2022

Myopic Choroidal Neovascularisation Trial in Beijing (CM082)

Suspended
  • Myopic Choroidal Neovascularisation
  • Beijing, China
    Peking Union Medical College Hospital
Mar 7, 2021

Real Life Study in Myopic Neovascularization

Active, not recruiting
  • Myopic Choroidal Neovascularisation
  • AFLIBERCEPT
  • Poitiers, France
    Chu de Poitiers
Sep 28, 2021

PIC and Its Role in Progression of Pathological Myopia

Unknown status
  • Punctate Inner Choroidopathy
    • Tokyo, Japan
      Tokyo Medical and Dental University
    Jun 15, 2021

    High Myopia: Extended and Longterm Observation of Pathologic

    Completed
    • Pathologic Myopia
    • Observation & Diagnosis
    • Regensburg, Bavaria, Germany
    • +25 more
    Jul 18, 2019

    Macular Disease Trial in Miki (ranibizumab, aflibercept, pegaptanib, verteporphin)

    Recruiting
    • Macular Disease
    • ranibizumab, aflibercept, pegaptanib, verteporphin
    • Miki, Kagawa, Japan
      Kagawa University Faculty of Medicine
    Mar 6, 2018

    Patterns With Lucentis in Approved Indications

    Completed
    • Neovascular AMD, Visual Impairment Due to DME, Visual Impairment Due to Macular Oedema Secondary to Branch or Central RVO, Visual Impairment Due to CNV
      • Tübingen, Germany
        Novartis Investigative Site
      Feb 28, 2017

      Choroid Neovascularization Secondary to Degenerative Myopia Trial in China (conbercept, Fixed, conbercept, PRN, sham injection)

      Unknown status
      • Choroid Neovascularization Secondary to Degenerative Myopia
      • conbercept, Fixed
      • +2 more
      • Beijing, Beijing, China
      • +12 more
      Jun 3, 2014

      Myopia, Pathological Trial in Worldwide (VEGF Trap-Eye (BAY86-5321), No Drug)

      Completed
      Has Results
      • Myopia, Pathological
      • VEGF Trap-Eye (BAY86-5321)
      • No Drug
      • Kowloon, Hong Kong
      • +19 more
      Apr 17, 2014

      VEGF and PEDF in Myopic Choroidal Neovascularization

      Completed
      • Myopic Choroidal Neovascularization
      • +2 more
        • Cambpobasso, CB, Italy
          Medical Retina Department, University of Molise
        Jun 25, 2014